top of page
About Uetliberg Pharmaceutical
Team Members
Clinical experts and researchers with highly-specialized experiences on glyco-epitope analysis and verification.
Translational platform to complete R&D processes.
Supported by academic institutions and industrial park.
Targeting glyco-epitopes
Uetliberg Pharmaceutical is uniquely positioned to translate laboratory discoveries to clinically applicable assays and therapies.
R&D Highlights
Highly specific and sensitive monoclonal antibodies for immunological assays of glyco-epitopes in cancer, allergy, and infectious diseases.
Robust mass spectrometry tests for measurement of glycosylated targets.
mRNA vaccines targeting glyco-eptipes in cancer.
CAR-T cells targeting glyco-epitopes in cancer.
bottom of page